HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
4.260
0.00 (0.00%)
At close: Jul 25, 2025, 4:00 PM
4.140
-0.120 (-2.82%)
After-hours: Jul 25, 2025, 7:53 PM EDT

HCW Biologics Stock Forecast

HCWB's stock price has decreased by -82.22% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for HCW Biologics stock has a target of 35, which predicts a 721.6% increase from the current stock price of 4.26.

Price Target: $35 (+721.6%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$35$35$35$35
Change+721.60%+721.60%+721.60%+721.60%
* Price targets were last updated on May 29, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for HCW Biologics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy333111
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total333111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Strong Buy
Maintains
$120$35
Strong BuyMaintains$120$35+721.60%May 29, 2025
EF Hutton
EF Hutton
Strong Buy
Initiates
$360
Strong BuyInitiates$360+8,350.70%Jun 1, 2023
EF Hutton
EF Hutton
Strong Buy
Reiterates
$360
Strong BuyReiterates$360+8,350.70%Apr 19, 2023
EF Hutton
EF Hutton
Strong Buy
Reiterates
$360
Strong BuyReiterates$360+8,350.70%Mar 30, 2023
EF Hutton
EF Hutton
Strong Buy
Reiterates
$360
Strong BuyReiterates$360+8,350.70%Mar 23, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
7.15M
from 2.57M
Increased by 178.36%
Revenue Next Year
n/a
from 7.15M
EPS This Year
-4.69
from -30.96
EPS Next Year
-5.11
from -4.69
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
4.10M-6.72M2.84M2.57M7.15M--
Revenue Growth
----57.73%-9.68%178.36%--
EPS
-59.70-27.41-16.64-27.83-30.96-4.69-5.11-2.77
EPS Growth
--------
Forward PE
--------
No. Analysts
-----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High7.4Mn/an/a
Avg7.1Mn/an/a
Low6.9Mn/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
186.5%
--
Avg
178.4%
--
Low
167.5%
--

EPS Forecast

EPS202520262027
High-4.83-5.26-2.86
Avg-4.69-5.11-2.77
Low-4.51-4.91-2.67

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.